A latest report by Investor Environmental Health Network states that investors who ignored health risks in cosmetics industry stand to lose. It is expected that improved health risk information, changes in European and U.S. regulation and increasing consumer pressure could cause trouble for the investors.
This is being regarded as a ticking bomb scenario where US FDA regulatory actions are only triggered when companies report themselves and this result in a system which allows significant consumer exposure to take place before rigorous safety testing takes place and at the end of the day puts the investors under huge risk.
Scientists have been pointing out that nanoparticles might reach the bloodstream and damage the lymph system and tissues. Though the health impact is broader in the cosmetic industry but their usage is posing a great concern since cosmetics companies are already implementing nanotechnology.
Via nanowerk





















